Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis

被引:29
|
作者
Vollenberg, Richard [1 ]
Tepasse, Phil-Robin [1 ]
Ochs, Kevin [1 ]
Floer, Martin [2 ]
Strauss, Markus [3 ]
Rennebaum, Florian [1 ]
Kabar, Iyad [1 ]
Rovas, Alexandros [4 ]
Nowacki, Tobias [1 ,5 ]
机构
[1] Univ Hosp Muenster, Dept Med B Gastroenterol Hepatol Endocrinol & Cli, D-48149 Munster, Germany
[2] Klinikum Ibbenburen, Dept Med 1, D-49477 Ibbenburen, Germany
[3] Univ Hosp Muenster, Dept Cardiol Coronary I Peripheral Vasc Dis Heart, D-48149 Munster, Germany
[4] Univ Hosp Muenster, Dept Med D, Div Gen Internal & Emergency Med Nephrol & Rheuma, D-48149 Munster, Germany
[5] Marienhosp Steinfurt, Dept Med Gastroenterol, D-48565 Steinfurt, Germany
来源
VIRUSES-BASEL | 2021年 / 13卷 / 11期
关键词
SARS-CoV-2; COVID-19; syndecan-1; glycocalyx; long-COVID-19; INFECTION;
D O I
10.3390/v13112324
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The COVID-19 pandemic is caused by the SARS CoV-2 virus and can lead to severe lung damage and hyperinflammation. In the context of COVID-19 infection, inflammation-induced degradation of the glycocalyx layer in endothelial cells has been demonstrated. Syndecan-1 (SDC-1) is an established parameter for measuring glycocalyx injury. This prospective, multicenter, observational, cross-sectional study analyzed SDC-1 levels in 24 convalescent patients that had been infected with SARS-CoV-2 with mild disease course without need of hospitalization. We included 13 age-matched healthy individuals and 10 age-matched hospitalized COVID-19 patients with acute mild disease course as controls. In convalescent COVID-19 patients, significantly elevated SDC-1 levels were detected after a median of 88 days after symptom onset compared to healthy controls, whereas no difference was found when compared to SDC-1 levels of hospitalized patients undergoing acute disease. This study is the first to demonstrate signs of endothelial damage in non-pre-diseased, convalescent COVID-19 patients after mild disease progression without hospitalization. The data are consistent with studies showing evidence of persistent endothelial damage after severe or critical disease progression. Further work to investigate endothelial damage in convalescent COVID-19 patients should follow.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients
    Sascha N. Goonewardena
    Olga G. Grushko
    Joanna Wells
    Lauren Herty
    Robert S. Rosenson
    Jacob M. Haus
    Scott L. Hummel
    Cardiovascular Drugs and Therapy, 2023, 37 : 307 - 313
  • [22] Obstetrical outcomes and follow-up for patients with asymptomatic COVID-19 at delivery: a multicenter prospective cohort study
    Hill, Jennifer
    Patrick, Haylea S.
    Ananth, Cande, V
    O'Brien, Devon
    Spernal, Suzanne
    Horgan, Rebecca
    Brandt, Justin S.
    Schwebel, Marlene
    Miller, Richard C.
    Straker, Michael J.
    Graebe, Robert A.
    Rosen, Todd
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2021, 3 (06)
  • [23] Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
    Abolghasemi, Hassan
    Eshghi, Peyman
    Cheraghali, Abdol Majid
    Fooladi, Abbas Ali Imani
    Moghaddam, Farzaneh Bolouki
    Imanizadeh, Sina
    Maleki, Matin Moeini
    Ranjkesh, Mohammad
    Rezapour, Mohammad
    Bahramifar, Ali
    Einollahi, Behzad
    Hosseini, Mohammad Javad
    Jafari, Nematollah Joneidi
    Nikpouraghdam, Mohamad
    Sadri, Nariman
    Tazik, Mokhtar
    Sali, Shanaz
    Okati, Shamsi
    Askari, Elham
    Tabarsi, Payam
    Aslani, Jafar
    Sharifipour, Ehsan
    Jarahzadeh, Mohammad Hossein
    Khodakarim, Nastaran
    Salesi, Mahmood
    Jafari, Ramezan
    Shahverdi, Samira
    TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (05)
  • [24] Long-Term Outcomes of COVID-19 and Risk Factors for Prolonged or Persistent COVID-19 in Lymphoma Patients: A Multicenter, Retrospective Cohort Study
    Lee, Jung Ah
    Han, Min
    Ahn, Sangmin
    Lee, Yongseop
    Yeom, Joon-Sup
    Choi, Jun Yong
    Ku, Nam Su
    Jeong, Su Jin
    Kim, Jung Ho
    Kim, Jin Seok
    Chung, Haerim
    Cho, Hyunsoo
    Kim, Yu Ri
    Ahn, Jin Young
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (41)
  • [25] Treatment of immunocompromised COVID-19 patients with convalescent plasma
    Fung, Monica
    Nambiar, Ashok
    Pandey, Suchi
    Aldrich, J. Matthew
    Teraoka, Justin
    Freise, Christopher
    Roberts, John
    Chandran, Sindhu
    Hays, Steven R.
    Bainbridge, Emma
    DeVoe, Catherine
    Roque Gardner, Annelys
    Yokoe, Deborah
    Henrich, Timothy J.
    Babik, Jennifer M.
    Chin-Hong, Peter
    TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (02)
  • [26] Effectiveness of convalescent plasma in Indian patients with COVID-19
    Budhiraja, Sandeep
    Dewan, Arun
    Aggarwal, Ritesh
    Singh, Omender
    Juneja, Deven
    Pathak, Sangeeta
    Singh, Y. P.
    Gupta, Ajay
    Rai, Reeta
    Indrayan, Abhaya
    Jha, Vinitaa
    Naithani, Rahul
    BLOOD CELLS MOLECULES AND DISEASES, 2021, 88
  • [27] Efficacy of convalescent plasma for the treatment of COVID-19 in lung transplant recipients: A multicenter French study
    Chaudhry, Abouzar
    Gallais, Floriane
    Falcoz, Pierre-Emmanuel
    De Verdiere, Sylvie Colin
    Villeneuve, Thomas
    Horeau, Delphine
    Chatron, Eva
    Blanchard, Elodie
    Collange, Olivier
    Renaud-Picard, Benjamin
    RESPIRATORY MEDICINE AND RESEARCH, 2025, 87
  • [28] Effect of inactivated COVID-19 vaccines on seizure frequency in patients with epilepsy: A multicenter, prospective study
    Fang, Xiqin
    Hu, Shimin
    Han, Tao
    Yang, Tingting
    Hu, Junji
    Song, Yucheng
    Li, Chunxiang
    Ma, Aihua
    Li, Yufeng
    Kong, Qingxia
    Tang, Liou
    Chen, Wei
    Sun, Wenxiu
    Fang, Chunyan
    Sun, Yanping
    Chen, Juan
    Sun, Wenying
    Yan, Yibing
    Gao, Yuxing
    Geng, Jianhong
    Li, Nan
    Li, Qiubo
    Jiang, Zhaolun
    Lv, Shishen
    Li, Wenke
    Lang, Xiaoling
    Wang, Suli
    Chen, Yanxiu
    Li, Baomin
    Li, Ling
    Liu, Xinjie
    Liu, Yong
    Zhan, Yan
    Gao, Zaifen
    Qu, Lixin
    Fu, Qingxi
    Liu, Xuewu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Echocardiographic parameters in COVID-19 patients and their association with ICU mortality: a prospective multicenter observational study
    Amarja Ashok Havaldar
    Merugu Vinay Kumar
    Raman Kumar
    Surya Prakash Yarramalle
    Mohammad Saif Khan
    Krushna Chandra Misra
    Shubhangi Kamble
    Atul Sangale
    Jay Prakash
    Munta Kartik
    Sumithra Selvam
    The Ultrasound Journal, 15
  • [30] Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study
    Yasin, Ayse Irem
    Aydin, Sabin Goktas
    Sumbul, Bilge
    Koral, Lokman
    Simsek, Melih
    Geredeli, Caglayan
    Ozturk, Akin
    Perkin, Perihan
    Demirtas, Derya
    Erdemoglu, Engin
    Hacibekiroglu, Ilhan
    Cakir, Emre
    Tanrikulu, Eda
    Coban, Ezgi
    Ozcelik, Melike
    Celik, Sinemis
    Teker, Fatih
    Aksoy, Asude
    Firat, Sedat T.
    Tekin, Omer
    Kalkan, Ziya
    Turken, Orhan
    Oven, Bala B.
    Dane, Faysal
    Bilici, Ahmet
    Isikdogan, Abdurrahman
    Seker, Mesut
    Turk, Haci M.
    Gumus, Mahmut
    FUTURE ONCOLOGY, 2022, 18 (10) : 1235 - 1244